Radium Life Tech Co FCF/Debt
Free Cash Flow to Debt Ratio of Radium Life Tech Co (2547.TW) as of Aug 14, 2026.
Get this data via API
Financial Data API
FCF/Debt
0.00
Last updated:
Free Cash Flow to Debt Ratio of Radium Life Tech Co is 2026 0.00 . Free Cash Flow to Debt Ratio of Radium Life Tech Co was 2025 -4.57 % . It decreases by % higher compared to the previous year.
Access this data via the Eulerpool API
Radium Life Tech Co Stock analysis
What does Radium Life Tech Co do? Radium Life Tech Co Ltd is a company that was founded in Taiwan in 2003 and specializes in the manufacture of medical devices and health products. The company has already received several awards for its innovative products and business strategy.
The business model of Radium Life Tech is to manufacture high-quality health products and medical devices and sell them through various distribution channels such as online shops, direct sales, pharmacies, and hospitals. The company relies on innovative technology and quality to satisfy its customers worldwide.
One important division of the company is the research and development of health products such as dietary supplements, vitamins, and minerals. The company works with various experts and researchers to develop products tailored to the needs of customers.
The company is also involved in the production of medical devices such as blood glucose meters and blood pressure monitors. These devices are designed for people with diabetes, hypertension, or heart disease and help them monitor and improve their health condition.
Another important division of the company is the production of beauty products such as anti-aging creams, skincare products, and hair care products. These products use the latest technologies and ingredients to care for and regenerate the skin and hair.
Radium Life Tech Co Ltd is also involved in the production of medical instruments such as surgical instruments or diagnostic devices. The company works closely with medical professionals and hospitals to develop and produce instruments that meet the requirements of the healthcare sector.
The company also has its own research and development department that focuses on the development of new products. They work on new technologies and manufacturing methods to create products that are of high quality and meet the needs of customers.
Radium Life Tech Co Ltd is not only active in Taiwan but also on an international level. The company already has branches in many countries and regions such as China, USA, Japan, and Europe. These branches help distribute and improve the company's products in the global market.
Overall, Radium Life Tech Co Ltd is an innovative and successful company specialized in the manufacture of medical devices and health products. The company has achieved a leading position in the market in a short period and has many exciting projects and products planned for the future. Radium Life Tech Co is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Radium Life Tech Co stock
On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Radium Life Tech Co since 2006 – with annual values, charts, and detailed analysis.
FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.
A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Radium Life Tech Co with sector peers and the industry average to assess whether it is attractive.
Access this data via the Eulerpool API
Leverage — Radium Life Tech Co
All Key Metrics — Radium Life Tech Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth